Flex Pharma Inc. | Ownership
Companies that own Flex Pharma Inc.
PRIMECAP Management Co.
662,900
3.67%
-1,148,400
0%
08/31/2018
The Vanguard Group, Inc.
337,859
1.87%
10,203
0%
06/30/2018
Columbia Management Investment Advisers LLC
281,004
1.56%
-545,837
0%
06/30/2018
Royce & Associates LP
264,274
1.46%
-66,546
0%
06/30/2018
Renaissance Technologies LLC
236,958
1.31%
108,358
0%
06/30/2018
Telemetry Investments LLC
110,708
0.61%
37,798
0.07%
06/30/2018
DWS Investment GmbH
78,968
0.44%
78,941
0%
06/30/2018
Geode Capital Management LLC
56,938
0.32%
0
0%
06/30/2018
BlackRock Fund Advisors
52,617
0.28%
6,716
0%
06/30/2018
Bridgeway Capital Management, Inc.
49,839
0.28%
-15,350
0%
06/30/2018
| Address |
31 St. James Avenue
Boston Massachusetts 02116
United States
|
|
Employees
|
- |
| Website |
http://www.flex-pharma.com |
| Updated |
07/08/2019 |
| Flex Pharma, Inc. operates as a biotechnology company. It engages in developing treatments for exercise-associated muscle cramps, nocturnal leg cramps and spasms associated with severe neuromuscular conditions. The company operates through the following business segments: Consumer Operations and Drug Development. |
